title: [The use of leukomax for potentiating combined chemotherapy of small cell lung cancer].
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: M B
authors.initials: MB
authors.lastname: Bychkov
authors.forename: N I
authors.initials: NI
authors.lastname: Perevodchikova
authors.forename: N F
authors.initials: NF
authors.lastname: Orel
authors.forename: N B
authors.initials: NB
authors.lastname: Smirnova
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor
vernacular_title: Ispol'zovanie leĭkomaksa s tsel'iu intensifikatsii kombinirovannoĭ khimioterapii melkokletochnogo raka lëgkogo.